127 related articles for article (PubMed ID: 34478262)
1. Penetration Cascade of Size Switchable Nanosystem in Desmoplastic Stroma for Improved Pancreatic Cancer Therapy.
Zhao X; Yang X; Wang X; Zhao X; Zhang Y; Liu S; Anderson GJ; Kim SJ; Li Y; Nie G
ACS Nano; 2021 Sep; 15(9):14149-14161. PubMed ID: 34478262
[TBL] [Abstract][Full Text] [Related]
2. Sono-promoted drug penetration and extracellular matrix modulation potentiate sonodynamic therapy of pancreatic ductal adenocarcinoma.
Xiao H; Li X; Li B; Zhong Y; Qin J; Wang Y; Han S; Ren J; Shuai X
Acta Biomater; 2023 Apr; 161():265-274. PubMed ID: 36893956
[TBL] [Abstract][Full Text] [Related]
3. Nitric oxide-induced stromal depletion for improved nanoparticle penetration in pancreatic cancer treatment.
Chen X; Jia F; Li Y; Deng Y; Huang Y; Liu W; Jin Q; Ji J
Biomaterials; 2020 Jul; 246():119999. PubMed ID: 32247201
[TBL] [Abstract][Full Text] [Related]
4. Combination treatment of T1-44, a PRMT5 inhibitor with Vactosertib, an inhibitor of TGF-β signaling, inhibits invasion and prolongs survival in a mouse model of pancreatic tumors.
Hong E; Barczak W; Park S; Heo JS; Ooshima A; Munro S; Hong CP; Park J; An H; Park JO; Park SH; La Thangue NB; Kim SJ
Cell Death Dis; 2023 Feb; 14(2):93. PubMed ID: 36765032
[TBL] [Abstract][Full Text] [Related]
5. Vactosertib, TGF-β receptor I inhibitor, augments the sensitization of the anti-cancer activity of gemcitabine in pancreatic cancer.
Lee JE; Lee P; Yoon YC; Han BS; Ko S; Park MS; Lee YJ; Kim SE; Cho YJ; Lim JH; Ryu JK; Shim S; Kim DK; Jung KH; Hong SS
Biomed Pharmacother; 2023 Jun; 162():114716. PubMed ID: 37086509
[TBL] [Abstract][Full Text] [Related]
6. Pathophysiological role of microRNA-29 in pancreatic cancer stroma.
Kwon JJ; Nabinger SC; Vega Z; Sahu SS; Alluri RK; Abdul-Sater Z; Yu Z; Gore J; Nalepa G; Saxena R; Korc M; Kota J
Sci Rep; 2015 Jun; 5():11450. PubMed ID: 26095125
[TBL] [Abstract][Full Text] [Related]
7. Tumor-stroma TGF-β1-THBS2 feedback circuit drives pancreatic ductal adenocarcinoma progression via integrin α
Nan P; Dong X; Bai X; Lu H; Liu F; Sun Y; Zhao X
Cancer Lett; 2022 Mar; 528():59-75. PubMed ID: 34958892
[TBL] [Abstract][Full Text] [Related]
8. Up-regulation of L1CAM in pancreatic duct cells is transforming growth factor beta1- and slug-dependent: role in malignant transformation of pancreatic cancer.
Geismann C; Morscheck M; Koch D; Bergmann F; Ungefroren H; Arlt A; Tsao MS; Bachem MG; Altevogt P; Sipos B; Fölsch UR; Schäfer H; Müerköster SS
Cancer Res; 2009 May; 69(10):4517-26. PubMed ID: 19435915
[TBL] [Abstract][Full Text] [Related]
9. Extracellular matrix-mediated membrane-type 1 matrix metalloproteinase expression in pancreatic ductal cells is regulated by transforming growth factor-beta1.
Ottaviano AJ; Sun L; Ananthanarayanan V; Munshi HG
Cancer Res; 2006 Jul; 66(14):7032-40. PubMed ID: 16849548
[TBL] [Abstract][Full Text] [Related]
10. Cancer-Associated Fibroblast-Targeted Delivery of Captopril to Overcome Penetration Obstacles for Enhanced Pancreatic Cancer Therapy.
Chen X; Jia F; Huang Y; Jin Q; Ji J
ACS Appl Bio Mater; 2022 Jul; 5(7):3544-3553. PubMed ID: 35786827
[TBL] [Abstract][Full Text] [Related]
11. Sequential delivery of nanoformulated α-mangostin and triptolide overcomes permeation obstacles and improves therapeutic effects in pancreatic cancer.
Feng J; Xu M; Wang J; Zhou S; Liu Y; Liu S; Huang Y; Chen Y; Chen L; Song Q; Gong J; Lu H; Gao X; Chen J
Biomaterials; 2020 May; 241():119907. PubMed ID: 32120315
[TBL] [Abstract][Full Text] [Related]
12. Stromal Modulation Reverses Primary Resistance to Immune Checkpoint Blockade in Pancreatic Cancer.
Zhao J; Xiao Z; Li T; Chen H; Yuan Y; Wang YA; Hsiao CH; Chow DS; Overwijk WW; Li C
ACS Nano; 2018 Oct; 12(10):9881-9893. PubMed ID: 30231203
[TBL] [Abstract][Full Text] [Related]
13. Perspectives of TGF-β inhibition in pancreatic and hepatocellular carcinomas.
Neuzillet C; de Gramont A; Tijeras-Raballand A; de Mestier L; Cros J; Faivre S; Raymond E
Oncotarget; 2014 Jan; 5(1):78-94. PubMed ID: 24393789
[TBL] [Abstract][Full Text] [Related]
14. Role of hyaluronan in pancreatic cancer biology and therapy: Once again in the spotlight.
Sato N; Kohi S; Hirata K; Goggins M
Cancer Sci; 2016 May; 107(5):569-75. PubMed ID: 26918382
[TBL] [Abstract][Full Text] [Related]
15. TGF-β Inhibitors in Metastatic Pancreatic Ductal Adenocarcinoma.
Alvarez MA; Freitas JP; Mazher Hussain S; Glazer ES
J Gastrointest Cancer; 2019 Jun; 50(2):207-213. PubMed ID: 30891677
[TBL] [Abstract][Full Text] [Related]
16. Opportunities and delusions regarding drug delivery targeting pancreatic cancer-associated fibroblasts.
Liu H; Shi Y; Qian F
Adv Drug Deliv Rev; 2021 May; 172():37-51. PubMed ID: 33705881
[TBL] [Abstract][Full Text] [Related]
17. Stromal remodeling by the BET bromodomain inhibitor JQ1 suppresses the progression of human pancreatic cancer.
Yamamoto K; Tateishi K; Kudo Y; Hoshikawa M; Tanaka M; Nakatsuka T; Fujiwara H; Miyabayashi K; Takahashi R; Tanaka Y; Ijichi H; Nakai Y; Isayama H; Morishita Y; Aoki T; Sakamoto Y; Hasegawa K; Kokudo N; Fukayama M; Koike K
Oncotarget; 2016 Sep; 7(38):61469-61484. PubMed ID: 27528027
[TBL] [Abstract][Full Text] [Related]
18. Collagenase Nanoparticles Enhance the Penetration of Drugs into Pancreatic Tumors.
Zinger A; Koren L; Adir O; Poley M; Alyan M; Yaari Z; Noor N; Krinsky N; Simon A; Gibori H; Krayem M; Mumblat Y; Kasten S; Ofir S; Fridman E; Milman N; Lübtow MM; Liba L; Shklover J; Shainsky-Roitman J; Binenbaum Y; Hershkovitz D; Gil Z; Dvir T; Luxenhofer R; Satchi-Fainaro R; Schroeder A
ACS Nano; 2019 Oct; 13(10):11008-11021. PubMed ID: 31503443
[TBL] [Abstract][Full Text] [Related]
19. A tunable delivery platform to provide local chemotherapy for pancreatic ductal adenocarcinoma.
Indolfi L; Ligorio M; Ting DT; Xega K; Tzafriri AR; Bersani F; Aceto N; Thapar V; Fuchs BC; Deshpande V; Baker AB; Ferrone CR; Haber DA; Langer R; Clark JW; Edelman ER
Biomaterials; 2016 Jul; 93():71-82. PubMed ID: 27082874
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of TGF-β signalling in combination with nal-IRI plus 5-Fluorouracil/Leucovorin suppresses invasion and prolongs survival in pancreatic tumour mouse models.
Hong E; Park S; Ooshima A; Hong CP; Park J; Heo JS; Lee S; An H; Kang JM; Park SH; Park JO; Kim SJ
Sci Rep; 2020 Feb; 10(1):2935. PubMed ID: 32076068
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
